Rezolute , Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development of its lead drug candidate, ersodetug, for the treatment of congenital ...

AI is everywhere. It's in our smartphones, computers, and even used by big corporations and governments. From everyday work ...

Collaboration reinforces Conduit’s commitment to leveraging AI and cybernetics to reduce human error, lower costs, and accelerate timelines in drug development; Sarborg delivers ...

Microsoft sees a path to million qubit quantum computers within years via an entirely new kind of quantum computer using a ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...

Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...

Early adopters are seeing big gains in drug development ... and computing makes the impossible possible: we can slash development timelines from a decade to two or three years.

As the drug development landscape becomes more ... which can improve projections for development timelines and related targets. De-risking multi-year R&D investment forecasts through AI/ML ...

Conclusions Based on our LCAs of seven clinical trials spanning all four phases of development ... and the trial timelines for recruitment and treatment of the trial participants were well within the ...

Discover how Grail Inc. achieved 45% revenue growth, improved scalability with the updated Galleri test, and navigates legislative and market challenges.